C4 Therapeutics (CCCC) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.22% |
| Dec 31, 2025 | 29.04% |
| Sep 30, 2025 | -158.83% |
| Jun 30, 2025 | 63.78% |
| Mar 31, 2025 | -85.62% |
| Dec 31, 2024 | 25.70% |
| Sep 30, 2024 | -385.18% |
| Jun 30, 2024 | 72.55% |
| Mar 31, 2024 | 24.54% |
| Dec 31, 2023 | 21.81% |
| Sep 30, 2023 | -61.64% |
| Jun 30, 2023 | 42.65% |
| Mar 31, 2023 | -13.72% |
| Dec 31, 2022 | -3.95% |
| Sep 30, 2022 | -26.24% |
| Jun 30, 2022 | 16.55% |
| Mar 31, 2022 | -3.60% |
| Dec 31, 2021 | -39.84% |
| Sep 30, 2021 | -1.98% |
| Jun 30, 2021 | 27.80% |
| Mar 31, 2021 | -15.47% |
| Dec 31, 2020 | -49.99% |
| Sep 30, 2020 | 1.36% |
| Jun 30, 2020 | 12.43% |
| Mar 31, 2020 | -61.74% |